This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/28/15 - 3:56:00 PM ET (BATS BZX Real-time Price)
Div Yield: --
KOOL Day's Range
KOOL 52 Week Range
KOOL Business Summary
Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine.View KOOL key stats
Cesca Therapeutics Inc - KOOL - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Cesca Therapeutics Inc as a
Sell with a ratings score of D.
Report Snippet: We rate CESCA THERAPEUTICS INC (KOOL) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, feeble growth in its earnings per share and generally disappointing historical performance in the stock itself.